The Carlyle Group completed an investment in Knack RCM – a Woodbridge, New Jersey-based provider of tech-enabled, end-to-end revenue cycle management services – in Q4 2025. No press announcement was issued by either party. Healthcare Dealflow confirmed the close via Carlyle’s Q4 2025 earnings filing with the SEC, which listed Knack RCM as notable capital deployed during the quarter (Carlyle Q4 2025 8-K). The transaction had been reported as signed in August 2025, with the Economic Times citing people aware of the matter that Carlyle had agreed to acquire a significant majority stake at a valuation of approximately $500 million.
Read the full article: Carlyle Completes Investment in Knack RCM //
Source: https://healthcaredealflow.com/carlyle-completes-acquisition-of-knack-rcm/